OTCMKTS:ECIA

Encision Stock Forecast, Price & News

$0.62

0.00 (-0.16 %)

(As of 01/19/2021 02:07 PM ET)

Add

Compare

Today's Range

$0.47

Now: $0.62▼

$0.62

50-Day Range

$0.42

MA: $0.48▼

$0.63

52-Week Range

$0.35

Now: $0.62▼

$0.95

Volume720 shs

Average Volume11,152 shs

Market Capitalization$7.17 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.4

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. It sells its products through a network of direct and independent sales representatives. The company was founded in 1991 and is based in Boulder, Colorado.

Overall MarketRank^™

0.67 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Encision.

2.5 Community Rank

Outperform Votes
Encision has received 81 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Encision has received 83 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Encision has received 50.61% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Encision and other stocks. Vote “Outperform” if you believe ECIA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ECIA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Encision does not currently pay a dividend.
Dividend Growth
Encision does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Encision insiders have not sold or bought any company stock.
Percentage Held by Insiders
38.16% of the stock of Encision is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Encision is -62.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Encision is -62.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Encision has a P/B Ratio of 3.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:ECIA

Previous Symbol

CUSIPN/A

CIK930775

Webwww.encision.com

Phone303-444-2600

Employees30

Debt

Debt-to-Equity Ratio0.36

Current Ratio2.66

Quick Ratio1.53

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$7.67 million

Price / Sales0.93

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.19 per share

Price / Book3.26

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-200,000.00

Net Margins-2.50%

Return on Equity-8.19%

Return on Assets-3.60%

Miscellaneous

Outstanding Shares11,583,000

Market Cap$7.17 million

Next Earnings Date2/4/2021 (Estimated)

OptionableNot Optionable

$0.62

0.00 (-0.16 %)

(As of 01/19/2021 02:07 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ECIA News and Ratings via Email

Sign-up to receive the latest news and ratings for ECIA and its competitors with MarketBeat's FREE daily newsletter.

Encision (OTCMKTS:ECIA) Frequently Asked Questions

How has Encision's stock price been impacted by COVID-19 (Coronavirus)?

Encision's stock was trading at $0.60 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ECIA stock has increased by 3.2% and is now trading at $0.6190.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Encision?

Wall Street analysts have given Encision a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Encision wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Encision's next earnings date?

Encision is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Encision.

How were Encision's earnings last quarter?

Encision Inc. (OTCMKTS:ECIA) released its quarterly earnings results on Thursday, May, 14th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company earned $1.78 million during the quarter. Encision had a negative net margin of 2.50% and a negative return on equity of 8.19%.
View Encision's earnings history.

Who are some of Encision's key competitors?

Some companies that are related to Encision include InspireMD (NSPR), Vivos (RDGL), InVivo Therapeutics (NVIV), Ra Medical Systems (RMED), Hancock Jaffe Laboratories (HJLI), Interpace Biosciences (IDXG), Dynatronics (DYNT), INVO Bioscience (INVO), NeuroMetrix (NURO), Obalon Therapeutics (OBLN), Biostage (BSTG), Plus Therapeutics (PSTV), Lianluo Smart (LLIT), iNeedMD (NEMD) and Safeplus International (BIPHD).
View all of ECIA's competitors.

What other stocks do shareholders of Encision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), Allegheny Technologies (ATI), Digital Turbine (APPS), The Allstate (ALL), Achaogen (AKAO) and Adient (ADNT).

Who are Encision's key executives?

Encision's management team includes the following people:

Mr. Gregory J. Trudel, CEO, Pres & Director (Age 59, Pay $237.69k)
Mr. David W. Newton, Co-Founder, VP of Technology & Director (Age 73, Pay $114.5k)
Mr. Vern D. Kornelsen, Co-Founder & Independent Director (Age 87, Pay $5k)
Mr. Robert H. Fries, Contract Chief Financial Officer & Director (Age 71, Pay $74.19k)
Mr. Peter Geary, COO & VP of Operations (Age 62, Pay $163.07k)
Mr. Brian Jackman, VP of Marketing (Age 38)
Ms. Mala Ray, VP, Controller, Treasurer & Corp. Sec. (Age 61)

What is Encision's stock symbol?

Encision trades on the OTCMKTS under the ticker symbol "ECIA."

How do I buy shares of Encision?

Shares of ECIA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Encision's stock price today?

One share of ECIA stock can currently be purchased for approximately $0.62.

How big of a company is Encision?

Encision has a market capitalization of $7.17 million and generates $7.67 million in revenue each year. Encision employs 30 workers across the globe.

What is Encision's official website?

The official website for Encision is www.encision.com.

How can I contact Encision?

Encision's mailing address is 6797 WINCHESTER CIRCLE, BOULDER CO, 80301. The medical device company can be reached via phone at 303-444-2600.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here